• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强啡肽A-(1-13)酰胺碱性残基修饰对κ阿片受体选择性和阿片活性的影响。

Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.

作者信息

Snyder K R, Story S C, Heidt M E, Murray T F, DeLander G E, Aldrich J V

机构信息

College of Pharmacy, Oregon State University, Corvallis 97331.

出版信息

J Med Chem. 1992 Nov 13;35(23):4330-3. doi: 10.1021/jm00101a010.

DOI:10.1021/jm00101a010
PMID:1360025
Abstract

A series of dynorphin A-(1-13) amide (Dyn A-(1-13)NH2) analogues containing lysine or N epsilon-acetyllysine (Lys(Ac)) was prepared by solid-phase peptide synthesis and evaluated for opioid receptor affinity in radioligand binding assays and for opioid activity in the guinea pig ileum (GPI). Substitutions were made at positions 6, 7, 9, 11, and 13, the basic amino acids in the C-terminus of the peptide, in order to assess the individual contributions of these residues to the kappa opioid receptor affinity and selectivity of Dyn A-(1-13)NH2. While substitutions of Lys(Ac) for Arg in position 6 did not affect kappa receptor affinity, it enhanced affinity for mu and delta receptors and therefore caused a loss of kappa receptor selectivity. When Lys(Ac) was substituted for Arg9, kappa opioid receptor affinity was enhanced and kappa receptor selectivity was retained. Replacement for Arg7, Lys11, or Lys13 by Lys(Ac) resulted in both decreased affinity and selectivity for kappa receptors. These results demonstrate the importance of Arg6 to the receptor selectivity profile of Dyn A-(1-13)NH2 and indicate that, of the five basic residues in the C-terminus, only Arg9 can be replaced by a nonbasic residue without substantial loss of kappa opioid receptor selectivity.

摘要

通过固相肽合成制备了一系列含有赖氨酸或Nε-乙酰赖氨酸(Lys(Ac))的强啡肽A-(1-13)酰胺(Dyn A-(1-13)NH2)类似物,并在放射性配体结合试验中评估其对阿片受体的亲和力,在豚鼠回肠(GPI)中评估其阿片活性。在肽C末端的碱性氨基酸位置6、7、9、11和13进行取代,以评估这些残基对Dyn A-(1-13)NH2的κ阿片受体亲和力和选择性的各自贡献。虽然在位置6用Lys(Ac)取代精氨酸不影响κ受体亲和力,但它增强了对μ和δ受体的亲和力,因此导致κ受体选择性丧失。当用Lys(Ac)取代精氨酸9时,κ阿片受体亲和力增强且κ受体选择性得以保留。用Lys(Ac)取代精氨酸7、赖氨酸11或赖氨酸13导致对κ受体的亲和力和选择性均降低。这些结果证明了精氨酸6对Dyn A-(1-13)NH2受体选择性谱的重要性,并表明,在C末端的五个碱性残基中,只有精氨酸9可以被非碱性残基取代而不会大幅丧失κ阿片受体选择性。

相似文献

1
Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.强啡肽A-(1-13)酰胺碱性残基修饰对κ阿片受体选择性和阿片活性的影响。
J Med Chem. 1992 Nov 13;35(23):4330-3. doi: 10.1021/jm00101a010.
2
Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.强啡肽A(1-11)-NH2第3位残基修饰对κ受体选择性和效价的影响。
J Med Chem. 1996 Jun 21;39(13):2456-60. doi: 10.1021/jm950655o.
3
Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
Int J Pept Protein Res. 1992 Aug;40(2):89-96. doi: 10.1111/j.1399-3011.1992.tb01454.x.
4
Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.高效且具选择性的环强啡肽 A 类似物的设计与合成。2. 新型类似物
J Med Chem. 1993 Mar 19;36(6):750-7. doi: 10.1021/jm00058a012.
5
Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues.
J Med Chem. 1990 Jan;33(1):206-12. doi: 10.1021/jm00163a034.
6
Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.强啡肽A(1-11)-NH₂环内酰胺肽类似物的设计、合成及生物活性
J Med Chem. 1996 Mar 1;39(5):1136-41. doi: 10.1021/jm950369c.
7
[2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.缺乏N端氨基的[2',6'-二甲基酪氨酸]强啡肽A(1-11)-NH₂类似物:强效且选择性的κ阿片受体拮抗剂。
J Med Chem. 2001 Sep 13;44(19):3048-53. doi: 10.1021/jm0101186.
8
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.2位和5位之间侧链至侧链环化的环强啡肽A-(1-11)酰胺类似物的合成及阿片样活性。1. 3位取代。
J Med Chem. 2004 Jan 15;47(2):446-55. doi: 10.1021/jm030298e.
9
Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
J Med Chem. 1990 Jul;33(7):1874-9. doi: 10.1021/jm00169a007.
10
Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
Can J Physiol Pharmacol. 1986 Jun;64(6):673-8. doi: 10.1139/y86-111.

引用本文的文献

1
Genome Mining-Based Discovery of Blenny Fish-Derived Peptides Targeting the Mouse κ-Opioid Receptor.基于基因组挖掘发现靶向小鼠κ-阿片受体的鳚鱼衍生肽
Front Pharmacol. 2021 Oct 22;12:773029. doi: 10.3389/fphar.2021.773029. eCollection 2021.
2
Structure-Activity Relationships of [des-Arg]Dynorphin A Analogues at the κ Opioid Receptor.[去精氨酸]强啡肽A类似物在κ阿片受体上的构效关系
J Med Chem. 2016 Nov 23;59(22):10291-10298. doi: 10.1021/acs.jmedchem.6b01411. Epub 2016 Nov 8.
3
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
基于新型芬太尼-δ阿片受体拮抗剂的二价配体的开发与表征
Br J Anaesth. 2015 Apr;114(4):646-56. doi: 10.1093/bja/aeu454. Epub 2015 Feb 13.
4
Effect of anchoring 4-anilidopiperidines to opioid peptides.将 4-苯胺基哌啶锚定到阿片肽上的效果。
Bioorg Med Chem Lett. 2013 Jun 1;23(11):3434-7. doi: 10.1016/j.bmcl.2013.03.065. Epub 2013 Apr 3.
5
Molecular dynamics simulations predict a tilted orientation for the helical region of dynorphin A(1-17) in dimyristoylphosphatidylcholine bilayers.分子动力学模拟预测强啡肽A(1-17)螺旋区域在二肉豆蔻酰磷脂酰胆碱双层膜中呈倾斜取向。
Biophys J. 2000 Nov;79(5):2331-44. doi: 10.1016/S0006-3495(00)76479-4.
6
Characterization of peptide-oligonucleotide heteroconjugates by mass spectrometry.通过质谱法对肽 - 寡核苷酸杂合物进行表征。
Nucleic Acids Res. 1996 Oct 1;24(19):3866-72. doi: 10.1093/nar/24.19.3866.
7
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.δ阿片样物质模拟拮抗剂:设计新一代超选择性阿片肽的原型
Mol Med. 1995 Sep;1(6):678-89.